Quick Links
About MyBladderCancerTeam
Powered By
Learning you have bladder cancer is a moment no one can be prepared for. It’s natural to feel overwhelmed, scared, or unsure where to turn first. Some people might wonder first about their treatment options. For others, one of the most pressing questions might be, “What does this mean for the future?”
Understanding your prognosis — the likely course of the disease — can bring clarity during a confusing time. While no one can predict the future with absolute certainty, knowing what factors affect bladder cancer prognosis can help you ask the right questions, plan ahead, and feel more in control of your journey. In this article, we’ll guide you through what to expect and what to discuss with your cancer care team.
A prognosis is a medically informed prediction. It’s your doctor’s best estimate of what to expect from the cancer over time. It includes how the cancer may behave, how well it might respond to treatment, and your chances of recovery.
It’s important to remember that a prognosis is not a guarantee but a probability. Every person is different. Even people with the same stage of bladder cancer can have very different outcomes. Your overall health, the type of bladder cancer you have, and how well you respond to cancer treatment all play a role in the prognosis.
Some people want to know every detail about their prognosis. Others prefer to focus on one step at a time. Both approaches are valid. Your healthcare team is there to give you the information you need in the way that’s most helpful for you.
It’s common to hear about survival rates when discussing prognosis, but prognoses and survival rates are not the same. Survival rates are based on data from large groups of people. They show how many people are still alive a certain number of years after being diagnosed with the same kind of cancer. For example, the National Cancer Institute uses the five-year relative survival rate, which compares survival rates for people with cancer to the general population.
If the cancer is only in the inner lining of the bladder (known as non-muscle-invasive bladder cancer, or NMIBC), the five-year survival rate is about 97 percent. If the cancer has spread to the bladder wall, the rate is about 71 percent. If it has spread to distant body parts like bones or lungs (also called metastatic bladder cancer), the five-year survival rate drops to around 8 percent.
These numbers give a general picture, but they don’t predict what will happen to anyone in particular. Many factors, including newer bladder cancer treatment options, can lead to better outcomes than past data suggest.
Your prognosis depends on many factors. We’ll cover a few of the key factors your doctor will take into consideration.
Staging describes how deep the cancer has grown into the bladder wall and whether it has spread to lymph nodes or distant parts of the body. Stage 0 cancer (including carcinoma in situ) stays in the inner lining and has a good prognosis. Stage 1 or stage 2 cancers may grow into the bladder wall, while stage 3 involves nearby tissues or organs. Stage 4 cancer has spread to distant organs. Generally, the lower the stage at diagnosis, the better the long-term outlook.
The grade describes how abnormal the cancer cells look under a microscope and gives clues about how fast the tumor is likely to grow or spread. It’s determined by examining a sample of the tumor from a biopsy (tissue sample taken during surgery) under a microscope. Low-grade tumors look more like normal cells and tend to grow slowly. High-grade tumors look more irregular and are more likely to invade deeper layers. These are the most concerning for long-term prognosis because they’re more likely to recur (return) after treatment.
Your doctor might also classify your tumor as grade 1, 2, or 3. Grade 1 tumors look the most like normal cells, while grade 3 tumors look the most abnormal. Grade 3 tumors are most likely to return after treatment or spread into other areas of the body.
The type of bladder cancer you have also plays a role in determining your prognosis. Urothelial carcinoma is the most common type. It responds to many treatments, including transurethral resection of bladder tumor (TURBT), chemotherapy, and immunotherapy.
Squamous cell carcinoma (SCC) is less common but more aggressive. In SCC, the stage of the cancer has the biggest influence on prognosis. Surgery tends to offer the best outcomes compared to radiation therapy or chemotherapy.
Small cell carcinoma is also very rare (it makes up around 1 percent of all bladder cancers), but it is more aggressive than urothelial carcinoma. It’s often found at advanced stages in slightly younger ages than urothelial carcinoma (at a median age of 68 rather than 73), and it spreads quickly. Even with a combination of chemotherapy and radiation, long-term survival is low, especially in stage 3 or stage 4.
How far the cancer has spread plays a big role in shaping your prognosis. If the cancer remains within the bladder, especially in the inner layer, outcomes tend to be better. If it spreads to the urethra (the tube you pee through), urinary tract, nearby lymph nodes, or other parts of the body, it becomes harder to treat. Metastatic bladder cancer usually requires ongoing treatment and carries a more serious outlook.
Your overall health matters, too. People who are generally in good health can often tolerate treatments better. Other health problems, like heart disease or diabetes, may affect your ability to recover.
Older adults are more likely to develop bladder cancer and may face different treatment challenges. But age alone doesn’t determine your outcome — many older adults respond well to treatment.
What type of bladder cancer treatment you receive can also play a big role in shaping your prognosis. Your doctor will tailor your treatment plan based on the grade and stage of your cancer as well as your overall health.
Surgery is one of the most effective ways to treat bladder cancer. It can significantly improve prognosis, especially when you catch it early.
TURBT is commonly used for NMIBC. If the cancer is low-grade and removed completely, the prognosis is likely very good. However, bladder cancer has a high risk of coming back, so regular monitoring with imaging tests or a cystoscopy (a procedure that uses a thin camera to look inside the bladder) after surgery is critical.
Radical cystectomy, which involves removal of the entire bladder and nearby lymph nodes, is typically used for MIBC or high-grade tumors. It can also yield a positive prognosis, but there’s still a risk the cancer can return later.
Chemotherapy can play a role in improving bladder cancer prognosis by targeting cancer cells that surgery might miss. If you get chemotherapy before surgery (neoadjuvant chemo), it can shrink tumors and improve the chances of complete removal. If you get it after surgery (adjuvant chemo), it can reduce the risk of the cancer returning.
Immunotherapy has changed the outlook for people with advanced bladder cancer, especially when other treatments aren’t working. It works by helping the body’s immune system recognize and attack cancer cells. Bacillus Calmette-Guérin therapy (BCG) is widely used for non-muscle-invasive bladder cancer and can prevent recurrences for years. While not everyone responds, immunotherapy has become a reliable choice for improving prognosis in hard-to-treat cases.
Radiation may be an option for people who wish to avoid complete bladder removal or aren’t healthy enough for major surgery. When combined with chemotherapy, it offers a bladder-sparing approach with survival outcomes that can rival surgery in some cases. It’s also used to manage symptoms or slow cancer spread in metastatic bladder cancer. While radiation doesn’t guarantee a cure, it can improve both survival and quality of life.
A prognosis isn’t final — it can evolve. Your outlook may improve with treatment or change if the cancer returns. That’s why follow-up care is so important. To keep track of things, your doctor may use:
Staying on top of your care helps with catching problems early, and then your treatment plan can be adjusted if needed. If you have any questions about your prognosis, talk to your healthcare team. They’re there to keep you informed about your options and make sure you get the best care possible.
MyBladderCancerTeam is the social network for people with bladder cancer and their loved ones. On MyBladderCancerTeam, members come together to ask questions, give advice, and share their stories with others who understand life with bladder cancer.
How has your prognosis changed over the course of treatment? What do you wish you had known sooner? Share your experience in the comments below, or start a conversation by posting on your Activities page.
Get updates directly to your inbox.
Sign up for free!
Become a member to get even more
Your privacy is our priority.
We'd love to hear from you! Please share your name and email to post and read comments.
You'll also get the latest articles directly to your inbox.